Search

Author/Creator Miheller, Pal

2. Clinical efficacy, drug sustainability and serum drug levels in Crohn's disease patients treated with ustekinumab – A prospective, multicenter cohort from Hungary. Issue 2 (February 2022)

Authors:
Gonczi, Lorant; Szanto, Kata; Farkas, Klaudia; Molnar, Tamas; Szamosi, Tamas; Schafer, Eszter; Golovics, Petra A.; Barkai, Laszlo; Lontai, Livia; Lovasz, Barbara; Juhasz, Mark; Patai, Arpad; Sarang, Krisztina; Vincze, Aron; Sarlos, Patricia; Farkas, Alexandra; Dubravcsik, Zsolt; Toth, Tamas G.; M...
Journal:
Digestive and liver disease
Issue:
Volume 54:Issue 2(2022)
Page Start:
207
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial. (December 2020)

Authors:
Atreya, Raja; Peyrin-Biroulet, Laurent; Klymenko, Andrii; Augustyn, Monica; Bakulin, Igor; Slankamenac, Dusan; Miheller, Pal; Gasbarrini, Antonio; Hébuterne, Xavier; Arnesson, Karin; Knittel, Thomas; Kowalski, Jan; Neurath, Markus F; Sandborn, William J; Reinisch, Walter
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 5:Number 12(2020)
Page Start:
1063
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort. Issue 11 (November 2017)

Authors:
Gonczi, Lorant; Gecse, Krisztina B.; Vegh, Zsuzsanna; Kurti, Zsuzsanna; Rutka, Mariann; Farkas, Klaudia; Golovics, Petra A.; Lovasz, Barbara D.; Banai, Janos; Bene, Laszlo; Gasztonyi, Bea; Kristof, Tunde; Lakatos, Laszlo; Miheller, Pal; Nagy, Ferenc; Palatka, Karoly; Papp, Maria; Patai, Arpad; Sa...
Journal:
Inflammatory bowel diseases
Issue:
Volume 23:Issue 11(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Non-medical switch from the originator to biosimilar and between biosimilars of adalimumab in inflammatory bowel disease – a prospective, multicentre study. Issue 12 (December 2022)

Authors:
Lontai, Livia; Gonczi, Lorant; Balogh, Fruzsina; Komlodi, Nora; Resal, Tamas; Farkas, Klaudia; Molnar, Tamas; Miheller, Pal; Golovics, Petra A.; Schafer, Eszter; Szamosi, Tamas; Ilias, Akos; Lakatos, Peter L.
Journal:
Digestive and liver disease
Issue:
Volume 54:Issue 12(2022)
Page Start:
1639
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. S0642 Cobitolimod for Moderate-to-Severe Left-Sided Ulcerative Colitis (CONDUCT): A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial. (October 2020)

Authors:
Atreya, Raja; Peyrin-Biroulet, Laurent; Klymenko, Andrii; Augustyn, Monica; Bakulin, Igor; Slankamenac, Dusan; Miheller, Pal; Gasbarrini, Antonio; Hébuterne, Xavier; Arnesson, Karin; Knittel, Thomas; Kowalski, Jan; Neurath, Markus F.; Sandborn, William J.; Reinisch, Walter
Journal:
American journal of gastroenterology
Issue:
Volume 115:Supplement(2020)ACG Annual Meeting Abstracts 1
Page Start:
S322
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗